Literature DB >> 3042119

Norfloxacin: a new quinolone. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3042119      PMCID： PMC1268104     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

2.  Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors:  L L Shen; A G Pernet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 3.  Drug interactions of ciprofloxacin with other non-antibiotic agents.

Authors:  E Rubinstein; S Segev
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

4.  Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.

Authors:  R Vogel; N B Deaney; E M Round; M J VandenBurg; W J Currie
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

5.  Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

Authors:  S R Crider; S D Colby; L K Miller; W O Harrison; S B Kerbs; S W Berg
Journal:  N Engl J Med       Date:  1984-07-19       Impact factor: 91.245

6.  Use of norfloxacin in the treatment of acute diarrheal disease.

Authors:  H L Dupont; M L Corrado; J Sabbaj
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965

Review 7.  Review of the bioavailability and pharmacokinetics of oral norfloxacin.

Authors:  G E Stein
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965

8.  Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin.

Authors:  P C Johnson; C D Ericsson; D R Morgan; H L Dupont; F J Cabada
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Use of norfloxacin to treat chronic typhoid carriers.

Authors:  E Gotuzzo; J G Guerra; L Benavente; J C Palomino; C Carrillo; J Lopera; F Delgado; D R Nalin; J Sabbaj
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

10.  Norfloxacin: review of safety studies.

Authors:  M L Corrado; W E Struble; C Peter; V Hoagland; J Sabbaj
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.